Alkermes Shows Improved Relative Strength; Still Shy Of Benchmark

Blockhead

14 Oct 2024

The Relative Strength (RS) Rating for Alkermes (ALKS) moved up into a new percentile Monday, as it got a lift from 64 to 76.

↑ X

How To Find The Best IPO Stocks

See All Videos

NOW PLAYING How To Find The Best IPO Stocks

IBD's proprietary RS Rating measures technical performance by using a 1 (worst) to 99 (best) score that identifies how a stock's price action over the trailing 52 weeks stacks up against all the other stocks in our database.

Decades of market research reveals that the best stocks often have an 80 or better RS Rating as they launch their largest price moves. See if Alkermes can continue to rebound and hit that benchmark.

Can You Really Time The Stock Market?

Alkermes is trying to complete a cup without handle with a 32.88 buy point. See if the stock can break out in volume at least 40% above average.

The company reported negative growth for both the top and bottom lines last quarter. Alkermes is expected to release its next quarterly numbers on or around Oct. 23.

The company holds the No. 19 rank among its peers in the Medical-Biomed/Biotech industry group. ADMA Biologics (ADMA), Catalyst Pharmaceuticals (CPRX) and United Therapeutics (UTHR) are among the top 5 highly rated stocks within the group.

RELATED:

Biotech And Pharmaceutical Industry And Stock News

Which Stocks Are Showing Improved Technical Action?

Why Should You Use IBD's Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

Ready To Grow Your Investing Skills? Join An IBD Meetup Group!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2475137873"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2475137873\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2475137873?lang=en_US&edition=fundamental","thumbnail":"https://www.investors.com/wp-content/uploads/2017/05/IRU6-150x150.jpg","is_english":true,"pubTime":"2024-10-14 15:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2475137873","market":"us","top_or_hot":-1,"title":"Alkermes Shows Improved Relative Strength; Still Shy Of Benchmark","media":"Blockhead","content":"<html><body><div>\n<p>The Relative Strength (RS) Rating for <b>Alkermes</b> (ALKS) moved up into a new percentile Monday, as it got a lift from 64 to 76.</p>\n<span>\n<span>\n<span jw-video-key=\"ehvvvOwx\" vid-authors=\"RACHEL FOX\" vid-cat=\"Investor's Corner\" vid-date=\"01/23/2024\" vid-date-tmsp=\"1706014196\" vid-dom-id=\"8911995-670d5648cd096\" vid-id=\"8911995\" vid-image=\"https://www.investors.com/wp-content/uploads/2024/01/IC_IPOstocks-640x360.png\" vid-name=\"How To Find The Best IPO Stocks\" vid-repeat=\"1\" vid-top=\"\" vid-url=\"https://content.jwplatform.com/manifests/ehvvvOwx.m3u8\" vid-width=\"50\">\n<span>↑</span>\n<span>X</span>\n<span>\n<span></span>\n<div>\n<div>\nHow To Find The Best IPO Stocks\n</div>\n<div>\nSee All Videos\n</div>\n</div>\n</span>\n<span>\n<span>NOW PLAYING</span>\n<span>How To Find The Best IPO Stocks</span>\n</span>\n</span>\n</span>\n</span>\n<p>IBD's proprietary RS Rating measures technical performance by using a 1 (worst) to 99 (best) score that identifies how a stock's price action over the trailing 52 weeks stacks up against all the other stocks in our database.</p>\n<p>Decades of market research reveals that the best stocks often have an 80 or better RS Rating as they launch their largest price moves. See if Alkermes can continue to rebound and hit that benchmark.</p>\n<hr/>\n<p>Can You Really Time The Stock Market? </p>\n<hr/>\n<p>Alkermes is trying to complete a cup without handle with a 32.88 buy point. See if the stock can break out in volume at least 40% above average.</p>\n<div><div></div></div>\n<p>The company reported negative growth for both the top and bottom lines last quarter. Alkermes is expected to release its next quarterly numbers on or around Oct. 23.</p>\n<p>The company holds the No. 19 rank among its peers in the Medical-Biomed/Biotech industry group. <b>ADMA Biologics</b> (ADMA), <b>Catalyst Pharmaceuticals</b> (CPRX) and <b>United <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a></b> (UTHR) are among the top 5 highly rated stocks within the group.</p>\n<p><strong>RELATED:</strong></p>\n<p>Biotech And Pharmaceutical Industry And Stock News</p>\n<p>Which Stocks Are Showing Improved Technical Action?</p>\n<p>Why Should You Use IBD's Relative Strength Rating?</p>\n<p>How Relative Strength Line Can Help You Judge A Stock</p>\n<p>Ready To Grow Your Investing Skills? Join An IBD Meetup Group!</p>\n</div></body></html>","source":"investor_business_daily_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alkermes Shows Improved Relative Strength; Still Shy Of Benchmark</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlkermes Shows Improved Relative Strength; Still Shy Of Benchmark\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-14 15:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/ibd-data-stories/alkermes-shows-improved-relative-strength-still-shy-of-benchmark/><strong>Blockhead</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Relative Strength (RS) Rating for Alkermes (ALKS) moved up into a new percentile Monday, as it got a lift from 64 to 76.\n\n\n\n↑\nX\n\n\n\n\nHow To Find The Best IPO Stocks\n\n\nSee All Videos\n\n\n\n\nNOW PLAYING...</p>\n\n<a href=\"https://www.investors.com/ibd-data-stories/alkermes-shows-improved-relative-strength-still-shy-of-benchmark/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1571399168.USD","symbol_name":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","start_time":0,"source_url":"https://www.investors.com/ibd-data-stories/alkermes-shows-improved-relative-strength-still-shy-of-benchmark/","article_id":"2475137873","we_media_id":null,"thumbnails":["https://www.investors.com/wp-content/uploads/2017/05/IRU6-150x150.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2475137873","pubTimestamp":1728889200,"columns":[],"sourceInfo":{"source_id":"investor_business_daily_highlight","name":"Investor’s Business Daily"},"weMediaInfo":null,"summary":"A Relative Strength Rating upgrade for Alkermes shows improving technical performance. Will it continue?","collect":0,"end_time":0,"defaultTopTitle":"investors.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","UTHR":"美国联合医疗","CPRX":"Catalyst Pharmaceutical Partners","LU1699723380.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"AP\" (USD) ACC","ALKS":"阿尔凯默斯","BK4139":"生物科技","ADMA":"ADMA Biologics Inc","BK4006":"钢铁","BK4532":"文艺复兴科技持仓","RS":"Reliance Steel & Aluminum Co"},"translate_title":"Alkermes显示出改善的相对强度；仍低于基准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADMA":1,"ALKS":1,"CPRX":1,"RS":1,"UTHR":1},"content_text":"The Relative Strength (RS) Rating for Alkermes (ALKS) moved up into a new percentile Monday, as it got a lift from 64 to 76.\n\n\n\n↑\nX\n\n\n\n\nHow To Find The Best IPO Stocks\n\n\nSee All Videos\n\n\n\n\nNOW PLAYING\nHow To Find The Best IPO Stocks\n\n\n\n\nIBD's proprietary RS Rating measures technical performance by using a 1 (worst) to 99 (best) score that identifies how a stock's price action over the trailing 52 weeks stacks up against all the other stocks in our database.\nDecades of market research reveals that the best stocks often have an 80 or better RS Rating as they launch their largest price moves. See if Alkermes can continue to rebound and hit that benchmark.\n\nCan You Really Time The Stock Market? \n\nAlkermes is trying to complete a cup without handle with a 32.88 buy point. See if the stock can break out in volume at least 40% above average.\n\nThe company reported negative growth for both the top and bottom lines last quarter. Alkermes is expected to release its next quarterly numbers on or around Oct. 23.\nThe company holds the No. 19 rank among its peers in the Medical-Biomed/Biotech industry group. ADMA Biologics (ADMA), Catalyst Pharmaceuticals (CPRX) and United Therapeutics (UTHR) are among the top 5 highly rated stocks within the group.\nRELATED:\nBiotech And Pharmaceutical Industry And Stock News\nWhich Stocks Are Showing Improved Technical Action?\nWhy Should You Use IBD's Relative Strength Rating?\nHow Relative Strength Line Can Help You Judge A Stock\nReady To Grow Your Investing Skills? Join An IBD Meetup Group!","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}